2015-2016 Session
Change SessionH.866
An act relating to prescription drug manufacturer cost transparency
- Sponsor(s)
- Location
- House Committee on Health Care
- Last Recorded Action
- House 5/2/2016 - Referred to the Committee on Health Care
Bill/Resolution Text
NOTE: to print information that appears on a tab within the bill page, use the Print link on that tab.
An act relating to prescription drug manufacturer cost transparency
Detailed Status
2015 - 2016 Legislative Session
| Body | Date | Journal | Calendar | Location | Full Status |
|---|
An act relating to prescription drug manufacturer cost transparency
Roll Call History
2015 - 2016 Legislative Session
| Body | Date | Journal | Location | Full Status |
|---|
Although procedurally bills and resolutions are assigned to only one committee at a time, other committees may review the bill or resolution. This page contains results from both the assigned committee as well as other committees.
An act relating to prescription drug manufacturer cost transparency
Committee Meetings
2015 - 2016 Legislative Session
| Meeting Date | Committee |
|---|
An act relating to prescription drug manufacturer cost transparency
Meeting Full List
2015 - 2016 Legislative Session
Thursday, January 21, 2016
- Committee(s):
- House Committee on Health Care
- 9:00 AM
-
H.866 - An act relating to prescription drug manufacturer cost transparency
9:00-10:30 AM. Overview of Issues.
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Brian Murphy, Pharmacy Program Director, Blue Cross/Blue Shield of Vermont
Michael Fischer MD MS, Associate Professor of Medicine, Harvard Medical School, Division of Pharmacoepidemiology & Pharmacoeconomics, Brigham & Women's
Ameet Sarpatwari JD PhD, Instructor, Harvard Medical School, Division of Pharmacoepidemiology & Pharmacoeconomics, Brigham & Women's
Aaron French, Deputy Commissioner, Health Services and Managed Care, Department of Vermont Health Access
Michael Ouellette, Clinical Pharmacy Manager, Goold Health Systems
Friday, January 22, 2016
- Committee(s):
- House Committee on Health Care
- 10:30 AM
-
H.866 - An act relating to prescription drug manufacturer cost transparency
Joint with several committees, Room 11.
Peter Welch, U.S. Congressman, Vermont
Representative Peter Welch and staff
Thursday, February 4, 2016
- Committee(s):
- House Committee on Health Care
- 2:00 PM
-
H.866 - An act relating to prescription drug manufacturer cost transparency
Legislation from other states regarding prescription drug cost transparency
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Tuesday, February 16, 2016
- Committee(s):
- House Committee on Health Care
- 2:30 PM
-
H.866 - An act relating to prescription drug manufacturer cost transparency
Wendy Morgan, Assistant Attorney General, Attorney General's Office
Merideth Chaudoir, Assistant Attorney General, Attorney General's Office
Jill Abrams, Assistant Attorney General, Attorney General's Office
Tuesday, February 23, 2016
- Committee(s):
- House Committee on Health Care
- 3:15 PM
-
H.866 - An act relating to prescription drug manufacturer cost transparency
Proposal re manufacturers' fee
Rep. Sarah Copeland-Hanzas
Tuesday, March 8, 2016
- Committee(s):
- House Committee on Health Care
- 4:30 PM
-
H.866 - An act relating to prescription drug manufacturer cost transparency
Or 4:45 PM. Brief discussion.
Rep. Douglas Gage
Rep. Christopher Pearson
Friday, March 11, 2016
- Committee(s):
- House Committee on Health Care
- 11:15 AM
-
H.866 - An act relating to prescription drug manufacturer cost transparency
Committee discussion of draft language re Rx drug cost transparency.
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Susan Barrett, JD, Executive Director, Green Mountain Care Board
Andrew MacLean, Lobbyist, MMR
- 2:45 PM
-
H.866 - An act relating to prescription drug manufacturer cost transparency
Mark-up and vote on Committee bill
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Wednesday, March 23, 2016
- Committee(s):
- House Committee on Health Care
- 11:00 AM
-
H.866 - An act relating to prescription drug manufacturer cost transparency
Kathryn Becker Van Haste, Director of Health Policy, Senator Bernie Sanders
Wednesday, March 30, 2016
- Committee(s):
- House Committee on Health Care
- 9:00 AM
-
H.866 - An act relating to prescription drug manufacturer cost transparency
John Murphy, Assistant General Counsel, PhRMA
James Love, Director, Knowledge Ecology International
Thursday, March 31, 2016
- Committee(s):
- House Committee on Health Care
- 9:15 AM
-
H.866 - An act relating to prescription drug manufacturer cost transparency
Susan Barrett, JD, Executive Director, Green Mountain Care Board
Rep. James McCullough, Sponsor of Amendment
Thomas Hall, Founder, Complementary and Alternative Medical Association of Vermont
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
- 11:00 AM
-
H.866 - An act relating to prescription drug manufacturer cost transparency
Leigh Purvis, Director of Health Services Research, AARP
Ritchard Engelhardt, State Director of Government Affairs, Northeastern and Western Regions, Biotechnology Innovation Organization
Tuesday, April 5, 2016
- Committee(s):
- House Committee on Health Care
- 4:15 PM
-
H.866 - An act relating to prescription drug manufacturer cost transparency
Reshma Ramachandran MD MPP, Research Faculty, Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health
Steven Knievel, Coordinator, Global Access to Medicines Program, Public Citizen
Wednesday, April 6, 2016
- Committee(s):
- House Committee on Health Care
- 9:00 AM
-
H.866 - An act relating to prescription drug manufacturer cost transparency
Dagny Hoff, State Health Insurance Program Coordinator, Central Vermont Council on Aging
Thursday, April 14, 2016
- Committee(s):
- House Committee on Health Care
- 5:00 PM
-
H.866 - An act relating to prescription drug manufacturer cost transparency
Rep. Pearson's proposed strike-all amendment
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Friday, April 15, 2016
- Committee(s):
- House Committee on Health Care
- 11:00 AM
-
H.866 - An act relating to prescription drug manufacturer cost transparency
Strike-all amendment from Rep. Pearson.
Margaret Laggis, Lobbyist, America's Health Insurance Plans
Other witnesses TBA.
Thursday, April 21, 2016
- Committee(s):
- House Committee on Health Care
- 10:00 AM
-
H.866 - An act relating to prescription drug manufacturer cost transparency
Amendments, Bancroft and Donahue; vote to amend H.866 with Donahue amendment; then vote out H.866 as amended.
Rep. Robert Bancroft
Rep. Anne B. Donahue
- 11:35 AM
-
H.866 - An act relating to prescription drug manufacturer cost transparency
Rep. McCullough amendment re complementary and alternative medicine
Committee Documents
An act relating to prescription drug manufacturer cost transparency
Witnesses Who Testified
2015 - 2016 Legislative Session
House Committee on Health Care
- Jill Abrams, Assistant Attorney General, Attorney General's Office
- Rep. Robert Bancroft
- Susan Barrett, JD, Executive Director, Green Mountain Care Board
- Jennifer Carbee, Legislative Counsel, Office of Legislative Council
- Merideth Chaudoir, Assistant Attorney General, Attorney General's Office
- Rep. Sarah Copeland-Hanzas
- Rep. Anne B. Donahue
- Ritchard Engelhardt, State Director of Government Affairs, Northeastern and Western Regions, Biotechnology Innovation Organization
- Michael Fischer MD MS, Associate Professor of Medicine, Harvard Medical School, Division of Pharmacoepidemiology & Pharmacoeconomics, Brigham & Women's
- Aaron French, Deputy Commissioner, Health Services and Managed Care, Department of Vermont Health Access
- Rep. Douglas Gage
- Thomas Hall, Founder, Complementary and Alternative Medical Association of Vermont
- Dagny Hoff, State Health Insurance Program Coordinator, Central Vermont Council on Aging
- Steven Knievel, Coordinator, Global Access to Medicines Program, Public Citizen
- Margaret Laggis, Lobbyist, America's Health Insurance Plans
- Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
- James Love, Director, Knowledge Ecology International
- Andrew MacLean, Lobbyist, MMR
- Rep. James McCullough, Sponsor of Amendment
- Wendy Morgan, Assistant Attorney General, Attorney General's Office
- Brian Murphy, Pharmacy Program Director, Blue Cross/Blue Shield of Vermont
- John Murphy, Assistant General Counsel, PhRMA
- Michael Ouellette, Clinical Pharmacy Manager, Goold Health Systems
- Rep. Christopher Pearson
- Leigh Purvis, Director of Health Services Research, AARP
- Reshma Ramachandran MD MPP, Research Faculty, Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health
- Ameet Sarpatwari JD PhD, Instructor, Harvard Medical School, Division of Pharmacoepidemiology & Pharmacoeconomics, Brigham & Women's
- Kathryn Becker Van Haste, Director of Health Policy, Senator Bernie Sanders
- Peter Welch, U.S. Congressman, Vermont
Fiscal notes and materials available on this web page are provided for informational purposes only, and may not comprise all materials received by the Vermont Legislature or the final fiscal information related to a specific bill. The Legislature is not responsible for the accuracy of any information in these materials, and their posting does not constitute approval or endorsement by the Legislature.
No fiscal documents found for H.866 in the 2015 - 2016 Legislative Session.
No committee of conference members found for H.866 in the 2015 - 2016 Legislative Session.
An act relating to prescription drug manufacturer cost transparency
Committee of Conference Meetings
2015 - 2016 Legislative Session
| Meeting Date | Committee |
|---|
